Login to Your Account

3SBio buys a larger stake in CP Guojian Pharma for $150M

By Pearl Liu
Staff Writer

Wednesday, January 27, 2016

HONG KONG – 3SBio Inc. continues along its expansionary path with a move to raise the stake it holds in Shanghai CP Guojian Pharmaceutical Co. Ltd. The latest acquisition is another step in a push toward full integration of the two companies.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription